SARS-CoV-2 Protein Subunit Recombinant Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SARS-CoV-2 Protein Subunit Recombinant Vaccine, covering 2025-06-03 to 2025-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children [Phase 3]